Clinical Trials Browser

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute

Esophageal Neoplasms, Stomach Neoplasms

Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Neoplasm Metastasis, Stomach Neoplasms

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Small Bowel Adenocarcinoma

Biliary Tract Neoplasms, Stomach Neoplasms

Stomach Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Carcinoma, Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Stomach Neoplasms

Gastrointestinal Neoplasms

Metastatic Small Intestinal Adenocarcinoma

Stomach Neoplasms

Locally Recurrent Rectal Cancer

Adenocarcinoma

Colorectal Neoplasms

Biliary Tract Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Rectal Neoplasms

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Colorectal Cancer Metastatic

Colonic Neoplasms

Cholangiocarcinoma

Pancreatic Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Pancreatic Cancer Metastatic to Liver

Pancreatic Neoplasms

Pancreatic Neoplasms

Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX

Clinical Trials

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

PANCREAS

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

CANTOR

PANC

CEIL

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

GRACIE

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

BIG

Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

OPTICAL-2

Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

SAIB

FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

NICER

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

TORCH-R

A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients

Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer

Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety

NaliCap

Peri-operative SLOG for Localized Pancreatic Cancer

RECTUM2015